Carol S. Portlock

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

46h-index8.4kcitations182works1.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(134), Chronic Lymphocytic Leukemia Research(56), Viral-associated cancers and disorders(34), Lung Cancer Treatments and Mutations(29), CNS Lymphoma Diagnosis and Treatment(28)

Publications182 total

Sequential R-CHOP/(R)-ICE and Dose-Adjusted EPOCH-R Are Both Appropriate Frontline Treatments for Newly Diagnosed Primary Mediastinal B-Cell Lymphoma: Results of a Retrospective Analysis
Blood·2024
Two Decade Single Institution Experience Highlights Rare Survivors with Relapsed or Refractory Burkitt Lymphoma
Blood·2024· 1 citedOpen Access
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP
Blood Advances·2024· 3 citedOpen Access
Data from The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
2023Open Access
Supplementary Figure S1 from The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
2023Open Access
Supplementary Figure Legends from The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
2023Open Access
Supplementary Figure Legends from The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
2023Open Access
Supplementary Figure S1 from The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
2023Open Access
Data from The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
2023Open Access
Involved-site radiotherapy for <i>Helicobacter pylori</i>–independent gastric MALT lymphoma: 26 years of experience with 178 patients
Blood Advances·2021· 30 citedOpen Access
Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue
Blood Advances·2021· 16 citedOpen Access
A genome-wide association study of marginal zone lymphoma shows association to the HLA region
UNC Libraries·2020Open Access
Interim Analysis from a Prospective Multicenter Study of Next-Generation Sequencing Minimal Residual Disease Assessment and CT Monitoring for Surveillance after Frontline Treatment in Diffuse Large B-Cell Lymphoma
Blood·2020· 9 cited
Expectant Management of Extranodal Marginal Zone Lymphoma of Bronchial-Associated Lymphoid Tissue (BALT)
Blood·2019· 2 cited
Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse
Blood Cancer Journal·2019· 119 citedOpen Access
Clinical presentation determines selection of patients for initial observation in mantle cell lymphoma
Haematologica·2019· 29 citedOpen Access
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma
Blood·2019· 56 citedOpen Access
ABVD plus rituximab <i>versus</i> ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study
Haematologica·2018· 14 citedOpen Access
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay
Blood Cancer Journal·2018· 34 citedOpen Access
A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL
Blood·2018· 64 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Andrew D. Zelenetz(29), Craig H. Moskowitz(28), David J. Straus(24), Ariela Noy(23), Paul A. Hamlin(18), Joachim Yahalom(15), Steven M. Horwitz(15), Owen A. O’Connor(12), Matthew J. Matasar(9), John F. Gerecitano(9), Alison J. Moskowitz(9), Daniel A. Filippa(8), Saul A. Rosenberg(8), Jing Qin(7), Heiko Schöder(7), Stephen D. Nimer(6), Anita Kumar(6), Anas Younes(6), Julie Teruya‐Feldstein(5), Maria Lia Palomba(5)